Concepedia

Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques

A:

Statistics

Publications

72

Citations

3.7K

Location

Limoges, France

Also known as RESINFIT · UMR INSERM 1092

Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques is a facility institution in Limoges, France known for medicine, antimicrobial resistance, and bacterial resistance.

HomepageROR

Top concepts

Publications

72

Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study)

Stephen Huang, Philippe Vignon, Armand Mekontso Dessap et al. · Intensive Care Medicine · 2022 · 104 citations · Full text

, , +10

Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program

Christine Robin, Anne Thiébaut, Sophie Alain et al. · Biology of Blood and Marrow Transplantation · 2020 · 73 citations · Full text

, , +15

Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial

Thomas Daix, Armelle Mathonnet, Scott C. Brakenridge et al. · Annals of Intensive Care · 2023 · 62 citations · Full text

Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature review and survey analysis

Yohann Lacotte, Christine Årdal, Marie-Cécile Ploy · Antimicrobial Resistance and Infection Control · 2020 · 28 citations · Full text

Prognostic significance of central venous-to-arterial carbon dioxide difference during the first 24 hours of septic shock in patients with and without impaired cardiac function

Grégoire Müller, E. Mercier, Philippe Vignon et al. · British Journal of Anaesthesia · 2017 · 27 citations

, , +10

1–5 of 72